BSGCT Online Seminar Series – From bench to business: my journey in gene therapy

04/03/2025
_bsgctmembers

Dr Killian Hanlon, CEO & Chief Scientist Lir Therapeutics

_bsgctmembers

previous post: Advanced genetic engineering of hematopoiesis: how to select the best engineering tool and expand target diseases and scope of intervention
next post: BSGCT Public & Patient Series Webinar – Liver directed lentiviral gene therapy for inherited cholestatic disorders